Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C

NCT02885168 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock

Interventions

DRUG: Recombinant Activated Protein C
DEVICE: Near-infrared spectroscopy (NIRS)
DRUG: Phenylephrine
BIOLOGICAL: Blood sample

Sponsor

Central Hospital, Nancy, France